HIV Central

• In 2018, 37.9 million people worldwide were living with HIV. Approximately 1.7 million were newly infected.¹
• While 79% of all people with HIV know their status, more than 8 million people are unaware of their infection.¹
• About 1.1 million people in the United States live with HIV, including 38,700 with new infections. About 1 in 7 do not know they are infected.²
• Only 62% of all people living with HIV had access to antiretroviral therapy in 2018.¹
• In the United States, the highest number of new HIV diagnoses are seen in men who have sex with men (MSM); black and Hispanic people are more likely to be infected with HIV than other racial and ethnic groups.³
• Despite their increased risk, nearly two-thirds of transgender men and women report never being tested for HIV. Testing rates among transgender women and men were comparable to testing rates among cisgender heterosexual men and women, a group at a much lower risk for HIV.⁴
• The leading cause of death among people living with HIV is tuberculosis. The disease results in about one in three AIDS-related deaths.¹
• Research indicates that when taken daily, pre-exposure prophylaxis (PrEP), reduces the risk for sexual transmission of HIV by roughly 99%. Efficacy of PrEP substantially lowers when it is not used consistently.⁵
• Since 2010, there has been a 16% reduction in new HIV infections and a 33% reduction in AIDS-related deaths.¹
• In 2013, UNAIDS announced their 90-90-90 goal that aims to have 90% of all people living with HIV know their status; 90% of all people who have been diagnosed with HIV on sustained antiretroviral treatment; and 90% of all people who receive antiretroviral therapy achieve viral suppression by 2020.⁶
• Two FDA-approved medications are currently available for PrEP in the U.S.: Truvada (emtricitabine/tenofovir disoproxil fumarate; Gilead Sciences) and Descovy (emtricitabine/tenofovir alafenamide; Gilead Sciences).⁷
• From 2010 to 2017, HIV diagnoses decreased 11% among U.S. adults and adolescents.⁷

References:

1. UNAIDS. Global HIV & AIDS statistics — 2019 fact sheet. Available at: https://www.unaids.org/en/resources/fact-sheet. Accessed September 19, 2019.
2. HIV.gov. U.S. Statistics. Available at: https://www.hiv.gov/hiv-basics/overview/data-and-trends/statistics. Accessed September 19, 2019.
3. HIV.gov. Who is at risk for HIV? Available at: https://www.hiv.gov/hiv-basics/overview/about-hiv-and-aids/who-is-at-risk-for-hiv. Accessed September 19, 2019.
4. Pitasi MA, et al. MMWR Morb Mortal Wkly Rep. 2017;doi:10.15585/mmwr.mm6633a3.
5. CDC. PrEP. Available at: https://www.cdc.gov/hiv/basics/prep.html. Accessed September 19, 2019.
6. UNAIDS. 90-90-90: An ambitious treatment target to help end the AIDS epidemic. Available at: https://www.unaids.org/en/resources/909090. Accessed September 19, 2019.
7. CDC. HIV in the United States and Dependent Areas.https://www.cdc.gov/hiv/statistics/overview/ataglance.html . Accessed on April 1, 2020.